Percentage of eyes with transient adverse events reported during the first week after treatment
| Adverse event | Latanoprost | 90° SLT | 180° SLT | 360° SLT |
|---|---|---|---|---|
| Discomfort/pain | 0% | 6% | 20% | 39% |
| Uveitis | 0% | 31% | 41% | 50% |
| IOP spike | 0% | 11% | 16% | 27% |
Percentage of eyes with transient adverse events reported during the first week after treatment
| Adverse event | Latanoprost | 90° SLT | 180° SLT | 360° SLT |
|---|---|---|---|---|
| Discomfort/pain | 0% | 6% | 20% | 39% |
| Uveitis | 0% | 31% | 41% | 50% |
| IOP spike | 0% | 11% | 16% | 27% |
Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of
BJO.
View free sample issue >>
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.